IBDEI0GG ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7631,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,7632,0)
 ;;=277.6^^35^474^5
 ;;^UTILITY(U,$J,358.3,7632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7632,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,7632,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,7632,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,7633,0)
 ;;=493.92^^35^474^6
 ;;^UTILITY(U,$J,358.3,7633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7633,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,7633,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,7633,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,7634,0)
 ;;=493.20^^35^474^11
 ;;^UTILITY(U,$J,358.3,7634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7634,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,7634,1,5,0)
 ;;=5^COPD with Asthma
 ;;^UTILITY(U,$J,358.3,7634,2)
 ;;=COPD with Asthma^269964
 ;;^UTILITY(U,$J,358.3,7635,0)
 ;;=493.91^^35^474^7
 ;;^UTILITY(U,$J,358.3,7635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7635,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,7635,1,5,0)
 ;;=5^Asthma, with Status Asthmat
 ;;^UTILITY(U,$J,358.3,7635,2)
 ;;=^269967
 ;;^UTILITY(U,$J,358.3,7636,0)
 ;;=491.21^^35^474^10
 ;;^UTILITY(U,$J,358.3,7636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7636,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,7636,1,5,0)
 ;;=5^COPD Exacerbation
 ;;^UTILITY(U,$J,358.3,7636,2)
 ;;=COPD Exacerbation^269954
 ;;^UTILITY(U,$J,358.3,7637,0)
 ;;=494.0^^35^474^9
 ;;^UTILITY(U,$J,358.3,7637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7637,1,4,0)
 ;;=4^494.0
 ;;^UTILITY(U,$J,358.3,7637,1,5,0)
 ;;=5^Bronchiectasis, chronic
 ;;^UTILITY(U,$J,358.3,7637,2)
 ;;=^321990
 ;;^UTILITY(U,$J,358.3,7638,0)
 ;;=494.1^^35^474^8
 ;;^UTILITY(U,$J,358.3,7638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7638,1,4,0)
 ;;=4^494.1
 ;;^UTILITY(U,$J,358.3,7638,1,5,0)
 ;;=5^Bronchiectasis with exacerb
 ;;^UTILITY(U,$J,358.3,7638,2)
 ;;=^321991
 ;;^UTILITY(U,$J,358.3,7639,0)
 ;;=496.^^35^474^12
 ;;^UTILITY(U,$J,358.3,7639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7639,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,7639,1,5,0)
 ;;=5^COPD, General
 ;;^UTILITY(U,$J,358.3,7639,2)
 ;;=COPD, General^24355
 ;;^UTILITY(U,$J,358.3,7640,0)
 ;;=491.20^^35^474^13
 ;;^UTILITY(U,$J,358.3,7640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7640,1,4,0)
 ;;=4^491.20
 ;;^UTILITY(U,$J,358.3,7640,1,5,0)
 ;;=5^Chronic Asthmatic Bronchitis
 ;;^UTILITY(U,$J,358.3,7640,2)
 ;;=Chronic Asthmatic Bronchitis^269953
 ;;^UTILITY(U,$J,358.3,7641,0)
 ;;=491.9^^35^474^14
 ;;^UTILITY(U,$J,358.3,7641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7641,1,4,0)
 ;;=4^491.9
 ;;^UTILITY(U,$J,358.3,7641,1,5,0)
 ;;=5^Chronic Bronchitis
 ;;^UTILITY(U,$J,358.3,7641,2)
 ;;=^24359
 ;;^UTILITY(U,$J,358.3,7642,0)
 ;;=786.2^^35^474^15
 ;;^UTILITY(U,$J,358.3,7642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7642,1,4,0)
 ;;=4^786.2
 ;;^UTILITY(U,$J,358.3,7642,1,5,0)
 ;;=5^Cough
 ;;^UTILITY(U,$J,358.3,7642,2)
 ;;=Cough^28905
 ;;^UTILITY(U,$J,358.3,7643,0)
 ;;=786.09^^35^474^16
 ;;^UTILITY(U,$J,358.3,7643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7643,1,4,0)
 ;;=4^786.09
 ;;^UTILITY(U,$J,358.3,7643,1,5,0)
 ;;=5^Dyspnea
 ;;^UTILITY(U,$J,358.3,7643,2)
 ;;=Dyspnea^87547
 ;;^UTILITY(U,$J,358.3,7644,0)
 ;;=492.8^^35^474^17
 ;;^UTILITY(U,$J,358.3,7644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7644,1,4,0)
 ;;=4^492.8
 ;;^UTILITY(U,$J,358.3,7644,1,5,0)
 ;;=5^Emphysema
 ;;^UTILITY(U,$J,358.3,7644,2)
 ;;=Emphysema^87569
 ;;^UTILITY(U,$J,358.3,7645,0)
 ;;=487.1^^35^474^24
 ;;^UTILITY(U,$J,358.3,7645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7645,1,4,0)
 ;;=4^487.1
 ;;
 ;;$END ROU IBDEI0GG
